Helena Barbosa Domingues da Hiemisch Lobo Borba

Dr. Helena Barbosa Domingues da Hiemisch Lobo Borba

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2018 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
MBMaria E. Balbi
Maria E. Balbi
FTFernanda Tonin
Fernanda Tonin
AMAntonio Eduardo Matoso Mendes
Antonio Eduardo Matoso Mendes
HBHelena Barbosa Domingues da Hiemisch Lobo Borba
Helena Barbosa Domingues da Hiemisch Lobo Borba
AWAstrid Wiens
Astrid Wiens
RPRoberto Pontarolo
Roberto Pontarolo
Vitamins are essential micronutrients with antioxidant potential that may provide a complementary treatment for patients with chronic diseases. Our aim was to assess the effect of vitamin supplementation on the antioxidant status and glycemic index of type 2 diabetes mellitus patients. We performed a systematic review with meta-analyses. Electronic searches were conducted in PubMed, Scopus, and Web of Science (December 2017). Randomized controlled trials evaluating the effect of any vitamin or vitamin complex supplementation on antioxidant status as primary outcome were included. The outcomes considered were: reduction of malondialdehyde (MDA); augmentation of glutathione peroxidase (GPx); changes in total antioxidant capacity (TAC), enhance in superoxide dismutase enzyme—SOD, and thiobarbituric acid reactive substances (TBARS). Outcomes of glycemic control were also evaluated. Pairwise meta-analyses were performed using software Review Manager 5.3. Thirty trials fulfilled the inclusion criteria, but only 12 could be included in the meta-analyses of antioxidant outcomes. The most commonly studied vitamins were B, C, D and E. Vitamin E was related to significant reduction of blood glucose as well as glycated hemoglobin compared to placebo, while both vitamins C and E were mainly associated with reducing MDA and TBARS and elevating GPx, SOD and TAC, compared to placebo. However, outcome reports in this field are still inconsistent (e.g. because of a lack of standard measures). Supplementation of vitamin E may be a valuable strategy for controlling diabetes complications and enhancing antioxidant capacity. The effects of other micronutrients should be further investigated in larger and well-designed trials to properly place these complementary therapies in clinical practice.

22 November 2016 in Mycoses
Verified
Journal Article
Closed access
PDF file
LSLaiza M. Steimbach
Laiza M. Steimbach
FTFernanda Tonin
Fernanda Tonin
SVSuzane Virtuoso
Suzane Virtuoso
HBHelena Barbosa Domingues da Hiemisch Lobo Borba
Helena Barbosa Domingues da Hiemisch Lobo Borba
ASAndréia C. C. Sanches
Andréia C. C. Sanches
RPRoberto Pontarolo
Roberto Pontarolo

9 May 2020 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
CMCamilla R. Madeira
Camilla R. Madeira
FTFernanda Tonin
Fernanda Tonin
MFMariana Millan Fachi
Mariana Millan Fachi
HBHelena Barbosa Domingues da Hiemisch Lobo Borba
Helena Barbosa Domingues da Hiemisch Lobo Borba
VFVinicius L. Ferreira
Vinicius L. Ferreira
RPRoberto Pontarolo
Roberto Pontarolo

17 August 2017 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
FTFernanda Tonin
Fernanda Tonin
LSLaiza M Steimbach
Laiza M Steimbach
HBHelena Barbosa Domingues da Hiemisch Lobo Borba
Helena Barbosa Domingues da Hiemisch Lobo Borba
ASAndreia C Sanches
Andreia C Sanches
AWAstrid Wiens
Astrid Wiens
FFFernando Fernandez-Llimos
Fernando Fernandez-Llimos
Objectives: Despite its broad spectrum, conventional amphotericin B (AB) is associated with serious adverse events. Lipid-based formulations may offer safer options. We aimed to synthesize the evidence of efficacy and safety of AB formulations. Methods: We performed a systematic review and network meta-analysis (NMA) to compare all available formulations: conventional AB; lipid complex or ABLC; colloidal dispersion or ABCD; liposomal or LAB; AB in Intralipid. Randomized controlled trials were searched in four databases. Cure, fever, chills, nephrotoxicity, death and drug discontinuation were assessed. NMA was based on Bayesian methods accounting for direct and indirect comparisons. Probability ranks estimating the best formulation were built for each outcome. The relative benefit–risk of formulations was assessed with stochastic multicriteria acceptability analyses (SMAA). Key findings: We identified 25 trials (n = 2996). No significant differences among drugs were observed for cure or death. All lipid-based formulations were safer than conventional AB for nephrotoxicity. AB-Intralipid was more tolerable than conventional AB and caused less chills than ABCD. AB-Intralipid was the best therapy (>60%) regarding nephrotoxicity, fever, chills and discontinuation. The scenario from SMAA favoured AB-Intralipid (81% acceptability). Conventional AB was secondary to all lipid-based formulations. Conclusions: Amphotericin B-Intralipid was identified as safer, cost-saving treatment in comparison with other formulations.

16 July 2018 in CNS Drugs
Verified
Journal Article
Closed access
PDF file
RLRosa C. Lucchetta
Rosa C. Lucchetta
FTFernanda Tonin
Fernanda Tonin
HBHelena Barbosa Domingues da Hiemisch Lobo Borba
Helena Barbosa Domingues da Hiemisch Lobo Borba
LLLetícia Leonart
Letícia Leonart
VFVinicius L. Ferreira
Vinicius L. Ferreira
AWAstrid Wiens
Astrid Wiens

12 June 2018 in Mycoses
Verified
Journal Article
Closed access
PDF file
HBHelena Barbosa Domingues da Hiemisch Lobo Borba
Helena Barbosa Domingues da Hiemisch Lobo Borba
LSLaiza Maria Steimbach
Laiza Maria Steimbach
BRBruno Salgado Riveros
Bruno Salgado Riveros
FTFernanda Tonin
Fernanda Tonin
VFVinicius Lins Ferreira
Vinicius Lins Ferreira
AWAstrid Wiens
Astrid Wiens